BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 7636239)

  • 21. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
    Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
    Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
    Blank U; Boitel B; Mège D; Ermonval M; Acuto O
    Eur J Immunol; 1993 Dec; 23(12):3057-65. PubMed ID: 8258318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes.
    Herrmann T; Romero P; Sartoris S; Paiola F; Accolla RS; Maryanski JL; MacDonald HR
    J Immunol; 1991 Apr; 146(8):2504-12. PubMed ID: 1707909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
    Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
    J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
    Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
    J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism.
    Yagi JJ; Rath S; Janeway CA
    J Immunol; 1991 Aug; 147(4):1398-405. PubMed ID: 1907996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
    Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
    J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
    Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
    Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens.
    Herrmann T; Baschieri S; Lees RK; MacDonald HR
    Eur J Immunol; 1992 Jul; 22(7):1935-8. PubMed ID: 1623932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge.
    Fattorossi A; Baschieri S; Ferlini C; Doria G
    Thymus; 1997; 24(3):133-45. PubMed ID: 9151379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Superantigens and antigen recognition of T lymphocytes].
    Gülmezoğlu E
    Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC bias of Mls-1 recognition is not influenced by thymic positive selection.
    Nguyen P; Woodland DL; Blackman MA
    Cell Immunol; 1996 Feb; 167(2):224-9. PubMed ID: 8603431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.